Abstract: Camptothecin (CPT), a natural DNA topoisomerase 1 inhibitor, is commonly used as a model hydrophobic compound for anticancer drug delivery research. Nanoparticle loaded with active drugs has the potential to selectively deliver the therapeutic agents into tumor cells without affecting the normal tissues, and hence is attracting tremendous attention from biomedical scientists. Nanoparticles can benefit from the enhanced permeability and retention effect (EPR) of the tumor tissues that allows nanoparticles to be transported through the leaky blood vessels and retained for a longer time compared with traditional small molecule drugs. In particular, covalent camptothecin conjugates are of extensive interest due to their robust stability by covalent chemical bonding. In this mini-review, recent progress of nanosized camptothecin conjugates will be discussed with the focus on the difference of delivery materials as well as their potential of combined drug delivery for the therapy of cancer.
Review mulating in the tumor cells due to the more leaky nature of tumor vasculature (27) . Generally, there are two ways to load the active cargo into the delivery vehicle, non-covalent encapsulation and covalent conjugation. In non-covalent encapsulation, drug molecules interact with the delivery materials by non-covalent bonding such as hydrogen bonding and π-π interaction, which offers the advantages of adjusting the dosage ratio accordingly and sometimes being able to deliver multi drugs as combination therapy to improve the efficiency of cancer treatment (28) . However, the weak non-covalent nature would normally lead to instability in releasing kinetics, causing burst release of drugs and the imprecise drug loadings percentage. As comparison, covalent conjugates, in which both drugs and materials are chemically bonded together, enable the delivery vehicle a predictable releasing profile, which can be adjusted by either the concentration of conjugates or the amounts of drugs attached (29) . In this mini-review, we will use natural cytotoxic product camptothecin as the model drug to discuss the recent development of nanosized drug conjugates for both single and combined drug delivery. Particularly we will be focused on the different selection of delivery materials as well as the potential use for combined drug delivery.
Introduction
Cancer is becoming one of the most deadly diseases faced by modern society (1) (2) (3) . Among various therapeutic methods, chemotherapy is playing an essential role as seen by the large quantity of prescriptions of chemotherapeutic drugs used in clinic annually (4, 5) . In spite of the fact that many patients can benefit from traditional chemo treatments, the strong toxicity, poor tissue selectivity, narrow therapeutic windows and related drug resistance greatly limit the use of chemotherapeutic drugs and worsen the life quality of cancer patients. Most toxicity of chemotherapy is related to the off-targeting of highly cytotoxic compounds (6, 7) , which result in the death of healthy tissue cells and malfunctioning of normal physiological signaling pathway. Therefore, a selective targeted drug delivery system is in critical need to precisely deliver the active drug with less usage to reduce the side effects and improve the biodistribution (8) (9) (10) (11) (12) (13) .
Nanotechnology has achieved huge accomplishments in the past few decades, providing scientists with lots of techniques to fabricate nanoparticles for different objectives (14) (15) (16) (17) (18) (19) (20) (21) (22) . From either top-down or bottom-up methods, we are now able to prepare nanoparticles with different shapes, sizes and chemical-physical properties both inside and outside (23) (24) (25) (26) . Because of their unique size range, nanoparticles are exhibiting "enhanced permeability and retention effect" (EPR) which shows that nanosized particles will be specifically targeting and accu-early 1960s, camptothecin has been used in research laboratories as the DNA topoisomerase 1 inhibitor (30, 31) . The antitumor efficacy of camptothecin comes primarily from the formation of ternary cleavable complex between topoisomerase 1, DNA and CPT so that the rapid replication of cancer DNA will be terminated, leading to the apoptosis and death of cancer cells (32) . Originated from Chinese tree Camptotheca (happy tree), camptothecin exhibits strong cytotoxicity against various tumor cell lines both in vitro and in vivo. However, the instability of E-lactone ring in camptothecin which leads to the inactive carboxylate form and poor aqueous solubility and biodistribution limited its clinical success ( Figure 1 ). Two of CPT derivatives, irinotecan and topotecan, have been successfully approved by FDA for the treatment of colon and ovarian cancer respectively with numerous other CPT compounds evaluated in clinical trials (33) (34) (35) (36) (37) . From chemistry standpoints, the five membered rings system gives camptothecin strong hydrophobicity and therefore can be used as model compound for hydrophobic drug delivery.
Nanoparticles from self-assembly of simple organic conjugates As described above, camptothecin is normally considered to be a hydrophobic chemical compound and needs another hydrophilic part in order to form the amphiphilic structure to allow the formation of nanoparticles. Very recently, Qin etc (38) reported nanosized self-assemblies built up from simple Camptothecin derivatives by directly diluting the stock dimethyl sulfoxide (DMSO) solutions with aqueous buffer. Three simple CPT compounds were evaluated (Figure 2a) , including (S)-(+)-CPT, 10-hydroxy-CPT and CPT succinic acid. The self-assembly occurring at low concentration of 5 X 10 -5 M resulted in the formation of helical nano-ribbons, flat nano-ribbons and short nano-rods, respectively. The authors also utilized HPLC analysis to prove the protection effect of CPT lactone from the self-assembly structure, which was further characterized by fluorescent spectra to be J-type self-assembly aggregates.
Similarly, the self-assembly of a small molecular camptothecin dimer was recently reported by Pei etc to show the formation of stable nanoparticles in aqueous solution with an average diameter of 30-50 nm (39) . A disulfide linker was incorporated into the structure which allows the nanoparticle to be responsive to the addition of external Glutathione (GSH). Those nanoparticles showed effective cytotoxicity against HeLa and HepG2 cancer cells with low IC 50 values of 1.82 and 0.44 µg/ml respectively. Internalization of the nanomedicine by HeLa cells was also observed on confocal laser scanning microscopy. These two findings provide very interesting foundations that camptothecin itself possesses great ability to self-assemble and form nanoparticles.
Self-assembly of short and oligopeptides into nanoparticles has becoming a very hot area during the past few years. Since only amino acids are used to constitute the assembly materials, these nanoparticles are ideal candidates for targeted drug delivery in terms of biocompatibility and systemic toxicity. Kim etc discovered the self-assembly of 20-(S)-Camptothecin-conjugated dipeptides into nanotubes with diameters ranging from 80-120 nm (40) . These nanoassemblies maintain a high (~47%) drug loading and exhibit greater drug stability (i.e., resistance to lactone hydrolysis), and consequently greater efficacy against several human cancer cells (HT-29, A549, H460, and H23) in vitro compared with the clinically used prodrug Irinotecan. A key and defining feature of this system is the use of the CPT-conjugated dipeptide as both the drug and precursor to the nanostructured carrier, which simplifies the overall fabrication process (Figure 2b) . Moreover, the authors also found the stability of nanotubes are greatly controlled the concentration of drug-peptide conjugates, which proves that the protection of active drug comes from the formation of nanoassemblies.
Cheetham etc conjugated one to four camptothecin molecules to a β-sheet-forming peptide sequence derived from the Tau protein through the reducible disulfylbutyrate (buSS) linker (41) . The drug loading of camptothecin can be precisely controlled as of 23%, 31% and 38% and electron microscopy revealed the self-assembly of these drug amphiphiles into either nano filamentous or nanotubes structures in water depending on the number of camptothecin attached on the Tau peptide. In vitro cytotoxicity was evaluated against human MCF-7 breast cancer cells and rat (9L and F98L) gliosarcoma lines. Interestingly, double CPT conjugated compound was consistently more effective than either quadruple or single CPT conjugates possibly because of its more balanced hydrophobic−hydrophilic ratio.
Besides natural amino acids, poly/oligo ethylene glycol can also serve as the hydrophilic part of self-assembly structure. Shen etc took the advantage of the strong hydrophobicity of camptothecin and conjugated it with short oligo ethylene glycol (OEG) (42) . Both single and dual CPT conjugates (OEG-CPT, OEG-DiCPT) self-assem- bled into liposome-like nanoparticles with drug loading as high as 58 wt% (Figure 2c ). Since the liposome particle has hydrophilic core, water-soluble doxorubicin salt (DOX) was successfully encapsulated inside and shown a synergetic cytotoxicity against cancer cells MCF-7. In vitro cytotoxicity study revealed DOX encapsulated CPT-nanoparticle to have the best antitumor activity compared with OEG-DiCPT, free CPT and free DOX in MCF-7 cells. Meanwhile, fast tumor suppression in xenografted SKOV-3 ovarian tumor model was observed, making these delivery systems promising for further pre-clinical studies.
Nanoparticles from self-assembly of polymers
Besides organic molecules self-assembly, polymers are also exhibits strong ability to form various nanostructures including nanofiber, nanobelt, nanosphere and hydrogels. By carefully adjusting the surface property and biocompatibility, polymers can be decorated with different active drugs and self-assemble into nanoparticles for targeted drug delivery (43) (44) (45) (46) .
Similar to the OEG strategy before, Zhou etc synthesized linear-dendritic camptothecin conjugates using PEG chain as the hydrophilic head while connecting the anticancer drug through a pre-formed disulfide linker (47) . The resulting amphiphilic camptothecin conjugates, containing up to 8 active drugs, self-assembled into spherical or rod shape nanoparticles stable at the physiological conditions. Difference in generation and number of the conjugated CPT molecules will change the nanostructure from sphere shape to rod shape as the number increases from one to eight. This again demonstrates that for self-assembly even a subtle change in the structure could lead to very different final results. Confocal microscopy and flow cytometry revealed that medium length nanorods (<500 nm) generally circulated longer in blood and was uptaken faster than the nanospheres or micrometer long nanorods, the latter of which will be removed from the blood stream and lung accumulation. This success displays that pegylated polymer drug conjugates can be ideal candidates for efficient tumor-drug delivery.
Not only can camptothecin be used as the hydrophobic part, researchers also demonstrated that camptothecin can act as the initiator in the polymerization process under certain condition. Tong (Figure 3a) , predefined drug loadings and controlled drug release kinetics (48, 49) . Nanoparticles with diameter range from 70nm to 200nm can be fabricated depending on different polymer-CPT ratio. In addition, such strategy shares the possibility to be applied in the conjugation of other hydroxyl-containing drugs to polyester nanoparticles, such as paclitaxel, doxorubicin, and docetaxel, for both single and combined drug delivery.
Stability has always been a vital issue for drug delivery especially for the self-assembled nanoparticle, which forms its inner structure by the cumulative noncovalent interactions. Although the inner interactive forces are strong enough to form nanostructures in vitro, in vivo stabilities of these nanoparticles are often questioned and concerned. Therefore, if one can crosslink and stabilize the nanoparticles after forming in vitro, it can be expected to maintain the desired nanostructures after administrated into circulation. Wang etc developed camptothecin-conjugated, core-cross-linked micelles with built-in disulfide bonds, which can be broken down and rapidly release CPT in reducing environment (50) . The crosslinking was achieved via the azide-alkyne click chemistry after the coprecipitation CPT-poly(tyrosine(alkynyl)-OCA) conjugate and monomethoxy poly(ethyleneglycol)-b-poly(tyrosine(alkynyl)-OCA) (Figure 3b ). The crosslinked nanoparticles exhibited excellent stability under physiological conditions, while maintaining effective cytotoxicity against MCF-7 human breast cancer cells in vitro. Remarkably, the IC 50 value against MCF-7 cancer cells decreased significantly from 2.24 to 0.76 μM with the pretreatment of GSH-OEt which increase the intracellular concentration of GSH and accelerate the controlled release of free CPT.
Click chemistry can also be used to link camptothecin to the backbone of biodegradable polymer to form micelle shape nanoparticles in aqueous solution. Zhang etc reported a reduction-cleavable polymer-camptothecin conjugate, in which a modified CPT is linked onto the pendant alkynes of biodegradable diblock polyphosphoester (PBYP-b-PEEP) via Cu (I)-catalyzed click chemistry (51) . The resulting polymer drug conjugate self-assembled into uniform micelles with diameter around 150nm. Similar to the research stated above, a releasable disulfide carbonate was selected to link the CPT and the polyphosphoester, which can result in the disruption of nanostructure under intracellular reducing environment, producing rapid release of active CPT. Furthermore, a live cell imaging system showed the internalization of prodrug micelles into liver cancer HepG2 cells to deliver the therapeutically active CPT.
Disulfide bonding is another method to introduce crosslinking with the self-assembled nanoparticles. Page etc synthesized a series of block copolymers based on 2-methacryloyloxyethyl phosphorylcholine (MPC) via reversible addition−fragmentation chain transfer (RAFT) polymerization (52) . Dihydrolipoic acid (DHLA) was also conjugated to the hydrophobic block, which resulted in the formation of block copolymer micelle nanoparticles in water. The nanoassemblies were relatively small with diameter range between 15 and 30 nm. Following the self-assembly, oxidation of the adjacent free thiol groups led to disulfide formation, which can crosslink the micelle core and make the nanoparticles stable in solution for weeks. Camptothecin (CPT) was then conjugated to the polymer backbone through a disulfide linkage, which helped the stabilization of camptothecin and slowed down the release of active drug compared with free CPT. This robust, water-soluble and redox-responsive nano drug delivery system set a great example of core-crosslinked micelle nanoparticle.
Hybrid silica nanoparticles for Camptothecin delivery
Using inorganic materials to construct nanoparticles such as gold and silica offers some unique characteristics compared with either simple organic or polymer self-assembly especially in stability and controllable sizes. Botella etc conjugated camptothecin with mercapto-functionalized silica nanoparticle with disulfide bond to form hybrid nanoparticles. Three different nanoparticles were obtained with different linker carbon number (53) . TEM pictures showed 50-60 nm average diameter particles are in majority. Since carbonate disulfide bond is presented in the structure, addition of DTT or GSH could lead to the reduction of disulfide bond and camptothecin can be released through an intramolecular cyclization mechanism or by carbonate bond hydrolysis. Interestingly, side chain length determines the drug release kinetics in aqueous medium. Longer side chain and more carbon number decreased the negative surface charge dramatically due to a shielding effect provoked by hydrophobic ligands, promoting aggregation and cell internalization. However, only shorter side chain can quickly deliver the free CPT by intramolecular cyclization while longer ones can only release CPT by carbonate hydrolysis.
As reported, the shape and size of nanomedicine have great impact on their circulation time and biological performance. Reduction of nanomedicine sizes to below 60 nm could substantially improve the penetration and retention of nanomedicine. To analyze the size effects of silica nanoparticle for anticancer drug delivery, Tang etc synthesized two camptothecin silica conjugated nanoparticles with monodisperse particle sizes of 50 and 200 nm (54) . Nanoparticles with 50 nm diameter were demonstrated to be better than 200 nm ones in terms of overall antitumor efficacy (Figure 4) . The resultant IC 50 values for 50nm and 200nm silica CPT nanoparticles in LNCaP prostate cancer cells were 510 and 800 nM respectively. Meanwhile, 50nm nanoparticles showed a 3-fold increased cellular internalization efficiency as compared to 200 nm ones. This study provides a promising clinical application of these optimized size nanoparticles for drug delivery.
Nanoparticles for combined drug delivery with Camptothecin
Drug resistance, especially multi drug resistance, is one of the most severe problems for chemotherapy and nano drug delivery, making patients less sensitive to the same drug and requires larger dosage to achieve the therapeutic effects (55, 56) . With the advancement of nano delivery, scientists can now deliver multiple therapeutic agents within one vehicle, aiming at either increase the selectivity or for combined drug delivery.
Folic acid (FA) is a popular targeting agent, which can help avoid nonspecific attacks on normal tissues as well as to increase their cellular uptake within target cells. Liu etc synthesized folic acid decorated amphiphilic poly(ethyleneglycol)-b-poly(ε-caprolactone) copolymers (57) . FA was employed as the hydrophilic head of polymer drug conjugates with disulfide bond linked to hydrophobic camptothecin. Self-assembly of the polymer drug conjugates was found to form micelles with size around 180 nm. The sensitivity of nanoparticles induced by reducing environment was confirmed from the changes of micelle sizes and morphologies. FA receptor mediated uptake and redox-sensitive release of CPT provide the nanoparticles with strong cytotoxicity against SKOV-3, MCF-7, and A549 cancer cells. The success of FA targeting and delivery of CPT demonstrate the advantages in combined therapy in enhancing cellular uptake at the tumor tissues and promoting intracellular release.
Using dual cytotoxic drugs to overcome the drug resistance problem is a commonly therapeutic method used in clinic. Cheetham etc prepared a mikto-arm star dual drug amphiphile containing both paclitaxel (PTX) and camptothecin (Figure 5a ). Both drugs were conjugated to a β-sheet forming peptide and three compounds were obtained during the synthesis, dual PTX, dual CPT and PTX- CPT conjugate (58) . The PTX-CPT conjugate could spontaneously self-assemble into nanofibers with 29% loading of PTX and 12% of CPT. Interestingly, among the three compounds synthesized, dual PTX conjugate self-assembled into micelle shape nanoparticles, in contrast to the nanofiber formed by the hetero PTX-CPT and dual CPT conjugates. Such result again proves that camptothecin have strong tendency to form self-assembly nanostructures. The PTX-CPT conjugate was found to effectively release both anticancer agents, exhibiting superior cytotoxicity against PTX-resistant cervical cancer cell, which proves that combined drug delivery by nanoparticles has the potential to overcome the drug resistance.
Self-assembly system can often form low-molecular-weight hydrogel which consists entangled nanorods/ nanofibers and traps water molecules to form the gel shape (59-61). Generally, the low-molecular-weight hydrogel is considered hydrophilic and suitable candidate for hydrophilic drug delivery. Ha etc conjugated CPT molecule to a class of low-molecular-weight poly-(ethylene glycol) (PEG) chains (MW = 500, 1000, and 2000), producing an amphiphilic prodrug (62) . The CPT-PEG conjugate formed stable hydrogels and could be loaded with water-soluble drug 5-fluorouracil (5-FU). Clinically 5-Fu is regularly in combined use with CPT drugs to enhance their anticancer activity. For example, folic acid, 5-Fu and Irinotecan are prescribed as combination under the name of FOLFIRI for the treatment of colorectal cancer. This success shows a great example of using supramolecular hydrogel for controlled dual drug release applications.
Not only chemotherapeutic drugs can be combined, specific nucleotides such DNA and siRNA can be delivered by nanoparticles with certain drug conjugates to independently access gene and protein targets, thereby circumventing drug resistance. Tang et al reported using an anticancer prodrug (CPTssR5H5) as a carrier to co-deliver camptothecin and small interfering RNA (siRNA) for overcoming multidrug resistance (MDR) (63) . CPT-siR-NA complexes possess cytotoxicity of 36 µM toward MDA-MB-231 cells, proving the efficacy in CPT delivery (Figure 5b) . Moreover, the disulfide linker allows efficient release of siRNA under reducing conditions, where the complex was taken up by MDA-MB-231 cells and the loaded MAP3K7 siRNA reduced the level of MAP3K7 mRNA. The results indicated that conjugate chemotherapeutic drug with certain nucleotides could be a promising way for addressing MDR problem. Tan et al also demonstrated the delivery of nucleic acid-drug conjugate that is composed almost entirely of payload molecules (64) . DNA nucleic acid has the necessary hydrophilicity to balance the hydrophobic camptothecin. 2-nitrobenzyl group was used as linker which can be cleaved by UV light (365 nm), releasing the DNA nanoparticles. Upon light activation, the DNA-CPT nanoparticles show localized cytotoxicity against SK-BR-3 cells with IC 50 value of 0.36µM compared with 13 µM when in the absence of UV light.
Conclusion
We have here demonstrated the recent progress of nanosized camptothecin conjugates for both single and combined drug delivery. With the advancement of nanotechnology, scientists can now prepare nanoparticles with different shapes, sizes and chemical-physical properties both inside and outside, providing enormous opportunities for targeted drug delivery. Enhanced permeability and retention effect empowers nanoparticles to be selectively targeting cancer cells to reduce the common toxicity associated with traditional chemotherapy. Self-assembly of nanoparticles from simple organic molecules and polymers enriches the selection of delivery materials, while inorganic materials such as silica nanoparticle also displays unique properties in terms of increased circular retention time. Additionally, combined drug delivery can also be achieved with nanoparticles with the promise to improve therapeutic efficiency and over drug resistance.
